fashion -WSS

fashion

author：focus 2025-10-01 02:12:43 - browse：722

As elite hunters of the immune system, T cells are constantly prowling our bodies for diseased cells to attack. But when they encounter a tumor, something unexpected can happen. New research shows that some cancer cells can fire a long nanotube projection into the T cell that, like a vampire’s fang, sucks energy-creating mitochondria from the immune cell, turning the predator into prey.

A study published this week in Cancer Cell investigated how cancer cells can rob mitochondria from T cells, shutting the immune cell down while energizing themselves. It may be yet another way cancer overcomes both the body’s defenses and resists many immunotherapies like CAR-T therapy and immune checkpoint blockade drugs, experts said.

“This is a new mechanism of immune evasion. It seems like the cancer cells are draining mitochondria from the T cells,” said Bo Li, a cancer researcher at the University of Pennsylvania and a senior author on the paper. “It’s really amazing. Some of my colleagues, their reaction was like, ‘I can’t believe this is true.’ I understand that. It’s just like the cancer cell is too smart.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Why you shouldn’t ask, “What country has the best health care?”

WSS

FTC sues over Novant Health acquisition of two N.C. hospitals

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

Time to name cancers by genetics, not organ of origin, expert says

Investment in vaccine development is lagging, report finds

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Why Medicare shouldn’t cover every FDA

hotspot

fashion

focus

What does generative AI mean for health care? We asked experts

Do digital therapeutics have a future in medicine?

George Santos makes 1st court appearance after pleading not guilty to 13 counts

White House pharmacy plagued with problems, investigation finds

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Why you shouldn’t ask, “What country has the best health care?”

Walensky prepares to leave CDC — and Congress — behind

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

DIEP, the 'gold standard' of breast reconstruction, is under threat

Vertex non

explore

Commercial surrogacy can be ethical, despite pope’s claims

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Boston competes with Raleigh

Readout Newsletter: The latest on Novavax, Merck, Bluebird

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

Novo Nordisk to expand supply of Wegovy for U.S. patients

Wikipedia

focus

hotspot

hotspot